Gonadotropin-releasing hormone agonist
3 papers1 finding
- 1 lab in 1 country
- Funders: Division of Diabetes, Endocrinology, and Metabolic Diseases and 4 more
- Human trial1
- Humans1
- Cells1
Outcomes
1BAT oxidative metabolism
downin humans1
1 study
BAT oxidative metabolism
downin humans1
Gonadotropin-releasing hormone agonist decreases BAT oxidative metabolism in humans (from 1.36 ± 0.66 min−1 to 0.91 ± 0.41 min−1).
“In premenopausal women who underwent gonadotropin-releasing hormone agonist, cold-stimulated BAT oxidative metabolism was reduced to a similar level (from 1.36 ± 0.66 min−1 to 0.91 ± 0.41 min−1) to that observed in postmenopausal women”
Human trialacute cold exposurebrown adipose tissue6 mofemalesn = 8
Brown adipose tissue metabolism in women is dependent on ovarian status
American journal of physiology. Endocrinology and metabolismMar 13, 2024
Latest
ENDO 2025 Abstract
SAT-729 Prediction of Vertebral Fractures in Breast Cancer Women Undergoing Endocrine Hormone Therapy
Cohort study of 172 peopleVertebral fracture
Bulletin of Experimental Biology and Medicine
Changes in Gene Transcription in Cumulus Cells from Women of Advanced Maternal Age under the Influence of Extracellular Vesicles from Follicular Fluid of Young Donors
Experiments in human cellsInterventions
American Journal of Physiology Endocrinology and Metabolism
Brown adipose tissue metabolism in women is dependent on ovarian status
Non-randomized trial in peopleOxidative phosphorylation